GlobeNewswire - News from Pennsylvania

Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock

Tue, 02 Mar 2021 14:00 GMT

BALA CYNWYD, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) (“Hamilton Lane”) today announced the pricing of an underwritten public offering by Hamilton Lane and certain selling stockholders of 1,453,110 shares of Class A common stock, in the aggregate, for gross proceeds of $128.2 million. The offering is expected to close on March 4, 2021, subject to customary closing conditions.

Aspinity Joins STMicroelectronics Partner Program to Deliver Complete AnalogML Solutions for Always-on Edge Processing

Tue, 02 Mar 2021 13:45 GMT

Analog machine learning pioneer aligns with leader in high-performance microcontrollers to support extended battery life in IoT devices

Analog machine learning pioneer aligns with leader in high-performance microcontrollers to support extended battery life in IoT devices

Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference

Tue, 02 Mar 2021 13:00 GMT

WARMINSTER, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference held virtually from March 9-10, 2021.

Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

Tue, 02 Mar 2021 12:30 GMT

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2020.

Strongbridge Biopharma plc Announces Submission of New Drug Application for RECORLEV? (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome to the U.S. Food & Drug Administration

Tue, 02 Mar 2021 12:30 GMT

~ RECORLEV? (levoketoconazole) New Drug Application is Supported by Previously-Reported Positive and Statistically Significant Results from the Phase 3 SONICS and LOGICS Studies ~

Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference

Tue, 02 Mar 2021 12:00 GMT

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.

Hamilton Lane Closes Latest Strategic Opportunities Fund Series on Nearly $900M

Tue, 02 Mar 2021 12:00 GMT

Sixth Series Designed to Target Private Credit Investments around the World

Sixth Series Designed to Target Private Credit Investments around the World

Recro to Present at H.C. Wainwright Global Life Science Conference

Tue, 02 Mar 2021 12:00 GMT

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright Global Life Science Conference. The conference, which will take place March 9-10, 2021, is being conducted with a virtual format.

TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

Tue, 02 Mar 2021 12:00 GMT

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report fourth quarter and full year 2020 financial results on March 24, 2021. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.??

Micro-Measurements’ New Portable Strain Gage Welding Unit Is Capable of 60 Welds per Minute Making it One of the Fastest Tools of Its Kind

Tue, 02 Mar 2021 11:00 GMT

The Model 700B welder is lightweight and is powered by longer life rechargeable batteries

The Model 700B welder is lightweight and is powered by longer life rechargeable batteries

Have You Lost Money Investing In Athenex, Inc. Securities? – Kehoe Law Firm, P.C. Class Action Investigation On Behalf Of ATNX Investors Who Have Suffered Losses Greater Than $50,000

Tue, 02 Mar 2021 01:29 GMT

PHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed against MultiPlan Corporation – MPLN; MPLN.WS

Tue, 02 Mar 2021 00:11 GMT

RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against MultiPlan Corporation (NYSE: MPLN; MPLN.WS) (“MultiPlan”) f/k/a Churchill Capital Corp. III (“Churchill III”) on behalf of: (1) those who purchased or acquired MultiPlan securities between July 12, 2020 and November 10, 2020, inclusive (the “Class Period”); and (2) all holders of Churchill III Class A common stock entitled to vote on Churchill III’s merger with and acquisition of Polaris Parent Corp. and its consolidated subsidiaries consummated in October 2020 (the “Merger”).

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Class Action Lawsuit Against Bit Digital, Inc. (BTBT)

Mon, 01 Mar 2021 23:41 GMT

RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Bit Digital, Inc. (NASDAQ: BTBT) (“Bit Digital”) on behalf of those who purchased or acquired Bit Digital securities between December 21, 2020 and January 8, 2021, inclusive (the “Class Period”).

STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mon, 01 Mar 2021 22:35 GMT

HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.?(NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that, as previously reported on its Form 8-K filed on March?1, 2021, effective as of the close of trading on March 1, 2021, the Company granted equity-based awards, in accordance with Nasdaq Listing Rule 5635(c)(4), to Robert Moccia as an inducement, material to Mr. Moccia entering into an employment agreement with the Company and commencing employment as its Chief Executive Officer and President. Mr. Moccia received an equity-based award of a stock option to purchase 1,632,590?shares of the Company’s common stock, with a strike price of $1.73 per share, vesting over a three year period, with 544,198 options vesting on the first anniversary of the date of grant and 136,049 options vesting every three months thereafter, provided in general that Mr. Moccia remains in the Company’s employ through each applicable vesting date and subject to the terms and conditions of the applicable award agreement.??

Vertex Announces Fourth Quarter and Full-Year 2020 Earnings Release and Conference Call Date

Mon, 01 Mar 2021 22:00 GMT

KING OF PRUSSIA, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced it will release fourth quarter and full-year 2020 earnings before the market opens on March 10, 2021. A conference call to discuss its results will follow at 8:30 a.m. Eastern Time that same day.

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Mon, 01 Mar 2021 21:35 GMT

ILLUMINATE-301 Continues on Track for Data Later this Month

ILLUMINATE-301 Continues on Track for Data Later this Month

Hamilton Lane Announces Public Offering of Class A Common Stock

Mon, 01 Mar 2021 21:23 GMT

BALA CYNWYD, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) (“Hamilton Lane”) today announced that it has commenced an underwritten public offering of 1,453,110 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and certain selling stockholders, subject to market and other conditions.?

CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results

Mon, 01 Mar 2021 21:15 GMT

Allentown, March 01, 2021 (GLOBE NEWSWIRE) --

CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

Mon, 01 Mar 2021 21:15 GMT

Full-Year 2020 Net Revenues of $172 Million Increased 11% Year-Over-Year, Driven by $50 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing

Cohen & Company Sets Release Date for Fourth Quarter and Full Year 2020 Financial Results

Mon, 01 Mar 2021 21:15 GMT

PHILADELPHIA and NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) will release its financial results for the fourth quarter and full year 2020 on Wednesday, March 3, 2021. The Company will host a conference call at 11:00 a.m. Eastern Time (ET) that morning to discuss these results.